These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 870694)

  • 41. The accuracy of psychiatric medication advertisements in medical journals.
    Spielmans GI; Thielges SA; Dent AL; Greenberg RP
    J Nerv Ment Dis; 2008 Apr; 196(4):267-73. PubMed ID: 18414120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do drug advertisements in Russian medical journals provide essential information for safe prescribing?
    Vlassov V; Mansfield P; Lexchin J; Vlassova A
    West J Med; 2001 Jun; 174(6):391-4. PubMed ID: 11381003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Content analysis of disease awareness advertisements in popular Australian women's magazines.
    Hall DV; Jones SC; Iverson DC
    Med J Aust; 2009 Dec 7-21; 191(11-12):625-9. PubMed ID: 20028287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An audit of food and beverage advertising on the Sydney metropolitan train network: regulation and policy implications.
    Sainsbury E; Colagiuri S; Magnusson R
    BMC Public Health; 2017 May; 17(1):490. PubMed ID: 28532472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
    Vandereycken W; Kuyken K
    Tijdschr Psychiatr; 2009; 51(6):407-11. PubMed ID: 19517371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of advertising on neurological drugs received during the medical consultation].
    Sanchez de Paz MP; Latella AN; Falero A; Lerman D; Bignone IMI; Rojas G
    Medicina (B Aires); 2021; 81(4):559-564. PubMed ID: 34453797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
    Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
    Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals.
    Lankinen KS; Levola T; Marttinen K; Puumalainen I; Helin-Salmivaara A
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):789-95. PubMed ID: 15486957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychoactive drug advertising: a comparison of technical information from three countries: Brazil, United States and United Kingdom.
    Mastroianni Pde C; Galduróz JC; Carlini EA
    Sao Paulo Med J; 2005 Sep; 123(5):209-14. PubMed ID: 16358094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journal.
    Yonemori K; Hirakawa A; Ando M; Hirata T; Yunokawa M; Shimizu C; Tamura K; Fujiwara Y
    PLoS One; 2012; 7(8):e44393. PubMed ID: 22952970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perpetuating stigma? Differences between advertisements for psychiatric and non-psychiatric medication in two professional journals.
    Foster JL
    J Ment Health; 2010 Feb; 19(1):26-33. PubMed ID: 20380495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of the legislation on the advertisement of psychoactive medications in Brazil.
    Mastroianni Pde C; Galduróz JC; Carlini EA
    Braz J Psychiatry; 2003 Sep; 25(3):146-55. PubMed ID: 12975688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Printed material distributed by pharmaceutical propaganda agents].
    Mejía R; Avalos A
    Medicina (B Aires); 2001; 61(3):315-8. PubMed ID: 11474880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Information contained in drug advertisements.
    Stimson GV
    Br Med J; 1975 Nov; 4(5995):508-9. PubMed ID: 1192148
    [No Abstract]   [Full Text] [Related]  

  • 55. Promotion by the British pharmaceutical industry, 1983-8: a critical analysis of self regulation.
    Herxheimer A; Collier J
    BMJ; 1990 Feb; 300(6720):307-11. PubMed ID: 2106963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.
    Cooper RJ; Schriger DL
    CMAJ; 2005 Feb; 172(4):487-91. PubMed ID: 15710940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advertising of medicines on New Zealand television.
    Norris P; Nelson L; Ling KL; Skellett L; Hoo J; Va'ai C; Gates A
    N Z Med J; 2005 May; 118(1215):U1462. PubMed ID: 15915185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
    Hall DV; Jones SC
    Aust N Z J Public Health; 2008 Oct; 32(5):471-8. PubMed ID: 18959553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Content audit of drug advertisements in Pakistan.
    Vakani F; Naqv K; Amin A
    Indian J Med Ethics; 2011; 8(3):167-9. PubMed ID: 22106645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How evidence-based are advertisements in journals regarding the subspecialty of rheumatology?
    van Winkelen P; van Denderen JS; Vossen CY; Huizinga TW; Dekker FW
    Rheumatology (Oxford); 2006 Sep; 45(9):1154-7. PubMed ID: 16531437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.